New injection could break cycle of painful joint bleeding in hemophilia
NCT ID NCT07187661
Summary
This study is testing whether a medication called Bevacizumab, injected directly into an inflamed joint, can reduce the frequency of painful bleeding episodes in people with hemophilia. The treatment aims to interrupt the cycle of inflammation and bleeding that damages joints over time. Researchers will measure changes in bleeding rates, joint health, and inflammation using MRI scans over several months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hayatabad Medical Complex
RECRUITINGPeshawar, KPK, 25000, Pakistan
Contact Email: •••••@•••••
Contact
Contact Email: •••••@•••••
-
Institute of Pathology and Diagnostic Medicine (IPDM)
RECRUITINGPeshawar, KPK, 25000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.